Protalix Biotherapeutics Inc (NYSE MKT:PLX) — Stock Price
Protalix Biotherapeutics Inc (NYSE MKT:PLX) is currently trading at $2.10 USD, up 3.45% today. Over the past 52 weeks, shares have ranged between $1.48 and $3.15. This page tracks Protalix Biotherapeutics Inc's live share price on the NYSE MKT exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PLX market cap overview.
Protalix Biotherapeutics Inc (PLX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Protalix Biotherapeutics Inc's daily closing share price and trading volume on the NYSE MKT exchange over the past year, giving a clear view of recent price momentum and liquidity.
Protalix Biotherapeutics Inc Income Statement — Revenue, Profit & Earnings by Year
Protalix Biotherapeutics Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $52.74 Million | $53.40 Million | $65.49 Million | $47.64 Million | $38.35 Million |
| Cost of Revenue | $26.99 Million | $24.32 Million | $22.98 Million | $19.59 Million | $16.35 Million |
| Gross Profit | $25.75 Million | $29.08 Million | $42.51 Million | $28.05 Million | $22.00 Million |
| Research & Development | $19.57 Million | $12.97 Million | $17.09 Million | $29.35 Million | $29.73 Million |
| SG&A | $11.68 Million | $40.79 Million | $25.46 Million | $-13.58 Million | $-4.02 Million |
| Total Operating Expenses | $31.25 Million | $25.16 Million | $32.05 Million | $41.06 Million | $42.46 Million |
| Operating Income | $-5.50 Million | $3.92 Million | $10.46 Million | $-13.01 Million | $-20.46 Million |
| EBITDA | $-4.04 Million | $6.52 Million | $12.94 Million | $-10.78 Million | $-18.94 Million |
| EBIT | $-5.50 Million | $5.22 Million | $11.75 Million | $-11.87 Million | $-20.06 Million |
| Interest Expense | $1.19 Million | $1.06 Million | $3.18 Million | $2.53 Million | $7.52 Million |
| Income Before Tax | $-5.61 Million | $4.15 Million | $8.57 Million | $-14.40 Million | $-27.58 Million |
| Income Tax Expense | $996.00K | $1.22 Million | $254.00K | $530.00K | $6.40 Million |
| Net Income | $-6.60 Million | $2.93 Million | $8.31 Million | $-14.93 Million | $-27.58 Million |
Protalix Biotherapeutics Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Protalix Biotherapeutics Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $82.35 Million | $73.42 Million | $84.43 Million | $55.79 Million | $73.67 Million |
| Total Current Assets | $66.67 Million | $60.08 Million | $69.93 Million | $44.88 Million | $61.67 Million |
| Cash & Equivalents | $14.68 Million | $19.76 Million | $23.63 Million | $17.11 Million | $38.98 Million |
| Short-term Investments | $15.59 Million | $15.07 Million | $20.93 Million | $5.07 Million | $38.98 Million |
| Net Receivables | $8.84 Million | $2.91 Million | $5.27 Million | $4.59 Million | $3.44 Million |
| Inventory | $25.73 Million | $21.24 Million | $19.05 Million | $16.80 Million | $17.95 Million |
| Property, Plant & Equipment | $12.58 Million | $10.02 Million | $10.88 Million | $9.64 Million | $9.92 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $34.12 Million | $30.21 Million | $50.87 Million | $66.43 Million | $79.70 Million |
| Total Current Liabilities | $26.52 Million | $25.62 Million | $45.53 Million | $32.43 Million | $33.18 Million |
| Long-term Debt | — | — | — | $28.19 Million | $27.89 Million |
| Net Debt | $-6.36 Million | $-14.23 Million | $4.06 Million | $16.36 Million | $-5.51 Million |
| Total Stockholder Equity | $48.23 Million | $43.21 Million | $33.57 Million | $-10.64 Million | $-6.04 Million |
| Retained Earnings | $-385.00 Million | $-378.39 Million | $-381.55 Million | $-389.86 Million | $-374.93 Million |
Protalix Biotherapeutics Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Protalix Biotherapeutics Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-11.99 Million | $8.67 Million | $-1.32 Million | $-25.00 Million | $-10.29 Million |
| Capital Expenditures | $1.64 Million | $1.28 Million | $1.15 Million | $628.00K | $1.46 Million |
| Free Cash Flow | $-13.63 Million | $7.39 Million | $-2.47 Million | $-25.63 Million | $-11.74 Million |
| Investing Cash Flow | $-2.37 Million | $4.22 Million | $-16.71 Million | $-5.04 Million | $18.92 Million |
| Financing Cash Flow | $9.33 Million | $-16.79 Million | $24.67 Million | $8.24 Million | $12.08 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $2.30 Million | $3.25 Million | $3.45 Million | $2.08 Million | $2.38 Million |
| Depreciation | $1.47 Million | $1.30 Million | $1.19 Million | $1.09 Million | $1.12 Million |
| Change in Cash | $-4.38 Million | $-3.87 Million | $6.52 Million | $-21.87 Million | $20.72 Million |
Protalix Biotherapeutics Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Protalix Biotherapeutics Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 08, 2026 | 0.00 | 0.06 | -100.00% |
| Mar 12, 2026 | -0.07 | 0.04 | -300.00% |
| Nov 13, 2025 | 0.03 | 0.07 | -57.14% |
| Aug 14, 2025 | -0.04 | 0.11 | -136.36% |
| May 08, 2025 | -0.05 | -0.02 | -150.00% |
| Mar 12, 2025 | 0.09 | 0.07 | +28.57% |
| Nov 04, 2024 | 0.03 | 0.06 | -50.00% |
| Aug 14, 2024 | -0.03 | 0.02 | -250.00% |